News

Net income was $2.61bn, compared to $2.48bn for the same period in the prior year. For the six months ended 2011 revenues were $33.49bn, compared to $33.71bn for

Caprelsa is indicated as a treatment of symptomatic or progressive medullary thyroid cancer in patients suffering from unresectable (non-operable) locally advanced or metastatic disease. The FDA approval for

Markison will also be a member of the board of the newly created standalone company, following the completion of the acquisition of Nycomed A/S by Takeda Pharmaceuticals. Previously,

The contracts are part of an ongoing effort to develop diagnostic tools and drugs to protect health and save lives in a radiological or nuclear emergency such as

The company expects to recruit patients in 70 centers in 11 European nations. In the trial, the preterm infants younger than 32 weeks of gestational age are randomized

Ridaforolimus is an investigational mTOR inhibitor being developed by Merck that has completed a Phase 3 clinical trial in patients with soft-tissue and bone sarcomas and is being

Livatag, which has been awarded orphan drug status in Europe and US, is a treatment presented in nanoparticles able to deliver doxorubicin in chemoresistant cells. The production for

The products include Neo-Polycin; Neo-Polycin HC; Polycin; Neomycin and Polymyxin B Sulfates with Dexamethasone Ophthalmic Ointments. Fera president Frank DellaFera said achieving this important milestone for their company,

Capsugel is a provider of drug delivery systems for the pharmaceutical, OTC and health and nutrition industries. Capsugel provides array of products and services, from hard gelatin, vegetarian